Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2021-03-26 History
Report ID 134811
Drug Identification Number 02230998
Brand name APO-DILTIAZ CD
Common or Proper name DILTIAZ
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-22
Estimated end date 2021-05-28
Actual end date
Shortage status Actual shortage
Updated date 2021-03-26
Company comments 100 bottle format is available
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-03-26 French Compare
v8 2021-03-26 English Compare
v7 2021-03-17 French Compare
v6 2021-03-17 English Compare
v5 2021-03-08 French Compare
v4 2021-03-08 French Compare
v3 2021-03-08 English Compare
v2 2021-02-26 French Compare
v1 2021-02-26 English Compare